|Basis of Allotment|
is only an advertisement for information purpose and not a prospectus announcement.)
SANGINITA CHEMICALS LIMITED
Our Company was incorporated as Sanginita Chemicals Private Limited
under the provisions of the Companies Act, 1956 vide certificate of incorporation dated
December 15, 2005 issued by the Asstt. Registrar of Companies, Gujarat, Dadra & Nagar
Haveli. Consequent upon the conversion of our Company into public limited company, the
name of our Company was changed to Sanginita Chemicals Limited and fresh certificate of
incorporation dated December 23, 2016 was issued by the Registrar of Companies, Ahmedabad
Gujarat. The Corporate Identification Number of our company is
Registered office: 301, 3rd Floor, Shalin Complex,
Sector -11, Gandhinagar - 382 011.
BASIS OF ALLOTMENT
PUBLIC ISSUE OF 45,66,000 EQUITY SHARES OF FACE VALUE OF RS 10/- EACH OF SANGINITA CHEMICALS LIMITED ("SCL" OR THE "COMPANY" OR THE ISSUER") FOR CASH AT A PRICE OF RS 22 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF RS 12 PER EQUITY SHARE (THE "ISSUE PRICE") AGGREGATING TO RS 1,004.52 LACS (THE ISSUE"), OF WHICH 2,34,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH FOR CASH AT A PRICE OF RS 22 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF RS 12 PER EQUITY SHARE AGGREGATING TO RS 51.48 LACS WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKER TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION i.e. NET ISSUE OF 43,32,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH AT A PRICE OF RS 22 PER EQUITY SHARE AGGREGATING TO RS 953.04 LACS IS HEREIN AFTER REFERRED TO AS THE "NET ISSUE". THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 26.44% AND 25.09%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY.
In terms of Prospectus dated February 23, 2017 and as per Regulation 43(4) of SEBI (ICDR) Regulations, 2009 wherein (a) minimum of 50 % of the Net Offer to Public shall be initially made available to Retail Individual Investors as the case may be (b) The balance net offer of shares to the public shall be made available for allotment to i) individual applicants other than retail investors; and ii) other investors including corporate bodies or institution irrespective of no. of shares applied for. Under subscription, if any, in any of the categories, would be allowed to be met with spillover from any of the other categories or a combination of categories at the discretion of our Company in consultation with the Lead Manager and the Designation Stock Exchange.
Explanation: for the purpose of Regulation 43(4) of SEBI (ICDR) Regulations, 2009, if the retail individual investor is entitled to more than fifty percent, on proportionate basis, the retail individual investors shall be allocated that higher percentage.
THE FACE VALUE OF THE EQUITY SHARES IS RS 10 EACH AND THE ISSUE PRICE IS
RS 22/- EACH. THE ISSUE PRICE IS 2.2 TIMES OF THE FACE VALUE.
The Equity Shares offered through the Prospectus are proposed to be listed on Emerge Platform of National Stock Exchange of India Limited ("NSE Emerge"). In terms of the Chapter XB of the SEBI (ICDR) Regulations, 2009, as amended from time to time, our ' Company has received an observation letter dated February 16, 2017 from NSE for using its name in this offer document for listing our shares on the Emerge Platform of National Stock Exchange of India Limited. For the purpose of this Issue, the designated Stock Exchange will be the NSE Limited ("NSE").
Details of the application
Detail of the valid Applications Received (Before Technical Rejection & withdrawal of application};
The 18 and 2 Applications received in retail individual investors category and other than retail individual investors category respectively were rejected on technical ground.
ALLOCATION; The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - National Stock Exchange of India Limited ('NSE Emerge") on 08th March. 2017.
A. Allocation to Market Maker: The Basis of Allotment to the Market Maker, at the issue price of Rs. 22/- per Equity Share, was finalised in consultation with NSE. The category was subscribed by 1 00 times. The total number of shares allotted in this category is 2,34,000 Equity shares in full out of reserved portion of 2,34,000 Equity Shares.
B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Retail Individual Investors, at the issue price of Rs.22/- per Equity Share, was finalized in consultation with NSE . The category was subscribed by 2.0978 times. Total number of shares allotted in this category is 2208000:
C. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs. 22/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 2.0989 times. Total number of shares allotted in this category is 21,24,000:
The Board of Directors of the Company at its meeting held on 08th March ,2017 has taken on record the Basis of Allocation of Equity Shares approved by the Designated Stock Exchange viz. NSE and has authorized the corporate action for the transfer of the Equity Shares/dispatch of share certificates to various successful applicants.
The CAN-cum-Refund Orders and allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories / as filled in the application form on or before 10th March, 2017. Further the instructions to Self Certified Syndicate Banks being processed on or prior to 9 th March. 2017. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equily Shares admitted for trading on the SME Platform of NSE Limited within six working days from the date of the closure of the Issue. The trading is proposed to be commenced on or before 14th March, 2017 subject to receipt of listing and trading approvals from the National Stock Exchange of India Limited ("NSE Emerge").
INVESTORS PLEASE NOTE
The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Purva Sharegistry (India) Private Limited at www.purvashare.com All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:
PURVA SHAREGISTRY INDIA PRIVATE LIMITED
THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET
PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF SANGINITA